Chemoinformaics analysis of Alkannin-beta-hydroxyisovalerate
| Molecular Weight | 388.416 | nRot | 6 |
| Heavy Atom Molecular Weight | 364.224 | nRig | 14 |
| Exact Molecular Weight | 388.152 | nRing | 2 |
| Solubility: LogS | -3.271 | nHRing | 0 |
| Solubility: LogP | 4.378 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 56.687 |
| nHD | 3 | BPOL | 28.417 |
| QED | 0.229 |
| Synth | 3.474 |
| Natural Product Likeliness | 1.399 |
| NR-PPAR-gamma | 0.303 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.554 |
| HIA | 0.927 |
| CACO-2 | -5.025 |
| MDCK | 0.0000234 |
| BBB | 0.004 |
| PPB | 0.977524 |
| VDSS | 0.612 |
| FU | 0.0684921 |
| CYP1A2-inh | 0.927 |
| CYP1A2-sub | 0.361 |
| CYP2c19-inh | 0.281 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.768 |
| CYP2c9-sub | 0.893 |
| CYP2d6-inh | 0.645 |
| CYP2d6-sub | 0.307 |
| CYP3a4-inh | 0.102 |
| CYP3a4-sub | 0.149 |
| CL | 6.4 |
| T12 | 0.896 |
| hERG | 0.002 |
| Ames | 0.647 |
| ROA | 0.153 |
| SkinSen | 0.924 |
| Carcinogencity | 0.209 |
| EI | 0.894 |
| Respiratory | 0.124 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.650963 |